by PEAK Medicals | 15 November 2024
DISKUSSIONSFORUM FÜR URO-ONKOLOGIE Neue Standards im Urothelkarzinom und das Management ihrer Nebenwirkungen Maria De Santis Prostatakarzinom: Wie lassen sich die neuen Therapien für mHSPC und mCRPC integrieren? Shahrokh F. Shariat Neue Behandlungsmöglichkeiten beim...
by PEAK Medicals | 6 November 2024
Antibody Drug Conjugates WELCOME & INTRODUCTION BY HOST Alessandra Curioni EMERGING TRENDS & CLINICAL IMPACT OF ADCs IN GENITOURINARY CANCERS Giuseppe Banna CURRENT AND FUTURE STANDARDS OF ADCs IN BREAST CANCER CARE Paolo Tarantino NEW DEVELOPMENTS IN LUNG CANCER CARE...
by PEAK Medicals | 5 June 2024
GU Cancers (ASCO 2024) Welcome & introduction by host Alex Friedlaender How do the data from ASCO integrate into the treatment of prostate cancer? Berna Özdemir Latest treatment advances for renal cell carcinoma Giuseppe Banna New breakthroughs in urothelial cancer...
by PEAK Medicals | 27 March 2024
Prostate & Urothelial Cancer Welcome & introduction by host Aurelius Omlin How to integrate the new treatment options in mHSPC and mCRPC Deborah Mukherji First-line mUC: how to manage patients on the enfortumab-pembrolizumab combination Alison Birtle Open...
by PEAK Medicals | 1 November 2023
ADC in Breast, GU & Lung Welcome & introduction by host Alfredo Addeo New ADCs in Breast Cancer Paolo Tarantino An Update on ADCs in GU Shilpa Gupta Novel ADCs in Lung Cancer Treatment Alfredo Addeo  } 1 h 31 min Get Your CME...
